Cargando…

A drug for improved radiosensitization in radiotherapy.

Detalles Bibliográficos
Autores principales:	Dische, S., Fowler, J. F., Saunders, M. I., Stratford, M. R., Anderson, P., Minchinton, A. I., Lee, M. E.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1980
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010462/ https://www.ncbi.nlm.nih.gov/pubmed/7426325

Ejemplares similares

In vivo assessment of basic 2-nitroimidazole radiosensitizers.
por: Williams, M. V., et al.
Publicado: (1982)

The concentration of desmethylmisonidazole in human tumours and in cerebrospinal fluid.
por: Dische, S., et al.
Publicado: (1981)

Clinical testing of the radiosensitizer Ro 07-0582: experience with multiple doses.
por: Dische, S., et al.
Publicado: (1977)

Continuous, hyperfractionated, accelerated radiotherapy (CHART).
por: Dische, S., et al.
Publicado: (1989)

Comparative studies of hypoxic-cell radiosensitization using artificially hypoxic skin in vivo.
por: Denekamp, J., et al.
Publicado: (1982)

The radiosensitizer Ro 03-8799 and the concentrations which may be achieved in human tumours: a preliminary study.
por: Saunders, M. I., et al.
Publicado: (1982)

Failure-specific prognostic factors after continuous hyperfractionated accelerated radiotherapy (CHART) or conventional radiotherapy in locally advanced non-small-cell lung cancer: A competing risks analysis
por: Ataman, Ö U, et al.
Publicado: (2001)

Serum concentration measurements in man of the radiosensitizer Ro-07-0582: some preliminary results.
por: Foster, J. L., et al.
Publicado: (1975)

p53 status of head and neck cancer: relation to biological characteristics and outcome of radiotherapy.
por: Wilson, G. D., et al.
Publicado: (1995)

Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer: an interim report. CHART Steering Committee.
por: Saunders, M. I., et al.
Publicado: (1996)

The effect of radiosensitizers on the pharmacokinetics of melphalan and cyclophosphamide in the mouse.
por: Hinchliffe, M., et al.
Publicado: (1983)

Enhancement of the cytotoxicity of radiosensitizers by modest hyperthermia: the electron-affinity relationship.
por: Rajaratnam, S., et al.
Publicado: (1982)

Combination studies with misonidazole and a cis-platinum complex: cytotoxicity and radiosensitization in vitro.
por: Stratford, I. J., et al.
Publicado: (1980)

Effect of hyperthermia on differential cytotoxicity of a hypoxic cell radiosensitizer, Ro-07-0582, on mammalian cells in vitro.
por: Stratford, I. J., et al.
Publicado: (1977)

Carbogen and nicotinamide in the treatment of bladder cancer with radical radiotherapy.
por: Hoskin, P. J., et al.
Publicado: (1997)

Cytotoxic properties of a 4-nitroimidazole (NSC 38087): a radiosensitizer of hypoxic cells in vitro.
por: Stratford, I. J., et al.
Publicado: (1981)

Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix.
por: West, C. M., et al.
Publicado: (1993)

Management of Adverse Effects Following Breast Radiotherapy: the report of the Maher Committee of the Royal College of Radiologists
por: Dische, S
Publicado: (1996)

Application of Radiosensitizers in Cancer Radiotherapy
por: Gong, Liuyun, et al.
Publicado: (2021)

Improving the efficacy of combined radiotherapy and immunotherapy: focusing on the effects of radiosensitivity
por: Gao, Zhiru, et al.
Publicado: (2023)

Whole brain radiotherapy with radiosensitizer for brain metastases
por: Viani, Gustavo Arruda, et al.
Publicado: (2009)

Gold Nanoparticles as Radiosensitizers in Cancer Radiotherapy
por: Chen, Yao, et al.
Publicado: (2020)

Application of Radiosensitizers in Cancer Radiotherapy [Corrigendum]
Publicado: (2021)

Radiosensitization of C3H Mouse Mammary Tumours by a 2-Nitroimidazole Drug
por: Sheldon, P. W., et al.
Publicado: (1974)

Enhancement of the effect of cytotoxic drugs by radiosensitizers.
por: Martin, W. M., et al.
Publicado: (1981)

The independence of intrinsic radiosensitivity as a prognostic factor for patient response to radiotherapy of carcinoma of the cervix.
por: West, C. M., et al.
Publicado: (1997)

TOPK modulates tumour-specific radiosensitivity and correlates with recurrence after prostate radiotherapy
por: Pirovano, Giacomo, et al.
Publicado: (2017)

Triggered radiosensitizer delivery using thermosensitive liposomes and hyperthermia improves efficacy of radiotherapy: An in vitro proof of concept study
por: Besse, Helena C., et al.
Publicado: (2018)

Integrating Radiosensitivity Gene Signature Improves Glioma Outcome and Radiotherapy Response Prediction
por: Wu, Shan, et al.
Publicado: (2022)

Editorial: Radiotherapy for esophageal cancer: Molecular mechanism and novel targets to improve radiosensitivity
por: Liu, Yanqing, et al.
Publicado: (2023)

Delivery of Nanoparticle-Based Radiosensitizers for Radiotherapy Applications
por: Boateng, Francis, et al.
Publicado: (2019)

Inlaying Radiosensitizer onto the Polypeptide Shell of Drug-Loaded Ferritin for Imaging and Combinational Chemo-Radiotherapy
por: Zhang, Qiuhong, et al.
Publicado: (2019)

Evaluation of Histone Deacetylase Inhibitors as Radiosensitizers for Proton and Light Ion Radiotherapy
por: Johnson, Alicia M., et al.
Publicado: (2021)

Enhancement of the cytotoxicity of SR 4233 to normal and malignant tissues by hypoxic breathing.
por: Minchinton, A. I., et al.
Publicado: (1992)

Investigation of Radiosensitivity Gene Signatures in Cancer Cell Lines
por: Hall, John S., et al.
Publicado: (2014)

Mitochondrial stress controls the radiosensitivity of the oxygen effect: Implications for radiotherapy
por: Richardson, Richard B., et al.
Publicado: (2016)

A review on lymphocyte radiosensitivity and its impact on radiotherapy
por: Paganetti, Harald
Publicado: (2023)

Tumour vascularity is a significant prognostic factor for cervix carcinoma treated with radiotherapy: independence from tumour radiosensitivity
por: Cooper, R A, et al.
Publicado: (1999)

Pretreatment apoptosis in carcinoma of the cervix correlates with changes in tumour oxygenation during radiotherapy
por: Sheridan, M T, et al.
Publicado: (2000)

Proceedings: Pyromellitic dianhydryde as radiosensitizer.
por: Astudillo, M. D., et al.
Publicado: (1975)

Cannot write session to /tmp/vufind_sessions/sess_p6c8cjf4g3ainm1bqj27mqe8bn